Familial Risks and Mortality in Second Primary Cancers in Melanoma

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53115

language	eng
Author	Chattopadhyay Subhayan Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany Hemminki Akseli Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland Foersti Asta Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland Sundquist Kristina Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY Center for Community-based Healthcare Research and Education (CoHRE) Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan Sundquist Jan Center for Primary Health Care Research, Lund University, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY Center for Community-based Healthcare Research and Education (CoHRE) Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan Hemminki Kari Center for Primary Health Care Research, Lund University, Malmö, Sweden
Journal Title	JNCI CANCER SPECTRUM
Volume	2
Issue	4
ISSN（Online）	2515-5091
Published Date	2018-10
DOI	10.1093/jncics/pky068
PubMed ID	31360883
Publisher	OXFORD UNIV PRESS
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This work was supported by The German Cancer Aid, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki and Helsinki University Central Hospital, and the Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE; Reg. no. 2013-1836), and FORTE (Reg. no. 2014-0804) and the Swedish Research Council (2012-2378 and 2014-10134) as well as ALF funding from Region Skane. The funding sources had no role in the study.